OCALIVA
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 08 Nov 2022)
What this means for you
Registered since 30 Aug 2016. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86710924
- Registration number
- 5033038
- Mark type
- Design + words
- Filed
- 31 Jul 2015
- Published for opposition
- 05 Apr 2016
- Registered
- 30 Aug 2016
- Attorney of record
- Jennifer Sheehan Anderson
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for human use for the treatment of chronic liver diseases
Owner
- INTERCEPT PHARMACEUTICALS, INC., Morristown, NJ, US
- INTERCEPT PHARMACEUTICALS, INC., NEW YORK, NY, US
- RXF Technologies, Inc., Royal Oak, MI, US
- RXF Technologies, Inc., Royal Oak, MI, US
Prosecution history
- 30 Aug 2025 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 08 Nov 2022 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 08 Nov 2022 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 08 Nov 2022 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 09 May 2022 — TEAS SECTION 8 & 15 RECEIVED
- 30 Aug 2021 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 09 Sept 2017 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 30 Aug 2016 — REGISTERED-PRINCIPAL REGISTER
- 26 Jul 2016 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 25 Jul 2016 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 14 Jul 2016 — STATEMENT OF USE PROCESSING COMPLETE
- 31 May 2016 — USE AMENDMENT FILED
- 27 Jun 2016 — RESPONSE TO ITU OFFICE ACTION ENTERED
- 11 Jul 2016 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 27 Jun 2016 — TEAS RESPONSE TO OFFICE ACTION RECEIVED